Advertisement

Index by author

March 01, 1981; Volume 216,Issue 3

A

  1. Abukhres, M M

    1. Influence of dietary sodium on renin angiotensin system involvement in sodium nitroprusside hypotension in conscious rats.
      R R Vollmer, E N Bush and M M Abukhres
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 580-585;

  2. Al-Turk, W A

    1. Effect of hypophysectomy and castration on hepatic, pulmonary and intestinal aryl hydrocarbon hydroxylase activities in the rat.
      W A Al-Turk, S J Stohs and E B Roche
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 492-495;

  3. Arbegast, P T

    1. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
      C S Sweet, D M Gross, P T Arbegast, S L Gaul, P M Britt, C T Ludden, D Weitz and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 558-566;

  4. Arbilla, S

    1. Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine.
      L A Kamal, S Arbilla and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 592-598;

B

  1. Backlund, E P

    1. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
      D M Gross, C S Sweet, E H Ulm, E P Backlund, A A Morris, D Weitz, D L Bohn, H C Wenger, T C Vassil and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 552-557;

  2. Barchas, J D

    1. Tyrosine hydroxylase: studies on the phosphorylation of a purified preparation of the brain enzyme by the cyclic AMP-dependent protein kinase.
      A M Edelman, J D Raese, M A Lazar and J D Barchas
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 647-653;

  3. Bloom, F E

    1. Interaction of ethanol and nutrition during gestation: influence on maternal and offspring development in the rat.
      S G Wiener, W J Shoemaker, L Y Koda and F E Bloom
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 572-579;

  4. Bohn, D L

    1. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
      D M Gross, C S Sweet, E H Ulm, E P Backlund, A A Morris, D Weitz, D L Bohn, H C Wenger, T C Vassil and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 552-557;

  5. Boyd, M R

    1. Renal toxicity due to reactive metabolites formed in situ in the kidney: investigations with 4-ipomeanol in the mouse.
      M R Boyd and J S Dutcher
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 640-646;

  6. Branch, R A

    1. Disposition of furosemide in functionally hepatectomized dogs.
      R K Verbeeck, J F Gerkens, G R Wilkinson and R A Branch
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 479-483;

  7. Britt, P M

    1. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
      C S Sweet, D M Gross, P T Arbegast, S L Gaul, P M Britt, C T Ludden, D Weitz and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 558-566;

  8. Bush, E N

    1. Influence of dietary sodium on renin angiotensin system involvement in sodium nitroprusside hypotension in conscious rats.
      R R Vollmer, E N Bush and M M Abukhres
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 580-585;

C

  1. Cauvin, C A

    1. Effect of reserpine pretreatment on in vivo femoral arterial responses to vasodilator agents.
      C A Cauvin, C J Devia and P L Kirkendol
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 447-452;

  2. Chan, P J

    1. Sex- and age-related mouse toxicity and disposition of the amino acid antitumor agent, acivicin.
      J P McGovren, G L Neil, P J Chan and J C Stewart
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 433-440;

  3. Chang, J K

    1. Hypotensive action of synthetic fragments of parathyroid hormone.
      P K Pang, M C Yang, T E Tenner, J K Chang and M Shimizu
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 567-571;

D

  1. Daum, A

    1. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
      M Gerold, R Eigenmann, F Hefti, A Daum and G Haeusler
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 624-633;

  2. Devia, C J

    1. Effect of reserpine pretreatment on in vivo femoral arterial responses to vasodilator agents.
      C A Cauvin, C J Devia and P L Kirkendol
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 447-452;

  3. Dewey, W L

    1. Effect of morphine exposure on mouse liver triglyceride formation.
      R G Lamb and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 496-499;

  4. Dieguez, G

    1. Analysis of the cerebrovascular effects of 5-hydroxytryptamine in unanesthetized goats.
      G Dieguez, B Gómez and S Lluch
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 599-603;

  5. Dutcher, J S

    1. Renal toxicity due to reactive metabolites formed in situ in the kidney: investigations with 4-ipomeanol in the mouse.
      M R Boyd and J S Dutcher
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 640-646;

E

  1. Edelman, A M

    1. Tyrosine hydroxylase: studies on the phosphorylation of a purified preparation of the brain enzyme by the cyclic AMP-dependent protein kinase.
      A M Edelman, J D Raese, M A Lazar and J D Barchas
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 647-653;

  2. Eigenmann, R

    1. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
      M Gerold, R Eigenmann, F Hefti, A Daum and G Haeusler
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 624-633;

  3. Erian, R

    1. Renal excretion of levamisole.
      G E Plante, R Erian and C Petitclerc
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 617-623;

F

  1. Faulkner, G D

    1. Inhibition of two monomeric butyrylcholinesterases from rabbit liver by chlorpromazine and other drugs.
      R S Rush, A R Main, B F Kilpatrick and G D Faulkner
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 586-591;

  2. Ferko, A P

    1. Ethanol and functional tolerance: interactions with pimozide and clonidine.
      M J Mullin and A P Ferko
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 459-464;

G

  1. Gardner, M L

    1. Behavioral effects of nicotine: schedule-controlled responding by squirrel monkeys.
      R D Spealman, S R Goldberg and M L Gardner
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 484-491;

  2. Gaul, S L

    1. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
      C S Sweet, D M Gross, P T Arbegast, S L Gaul, P M Britt, C T Ludden, D Weitz and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 558-566;

  3. Gerkens, J F

    1. Disposition of furosemide in functionally hepatectomized dogs.
      R K Verbeeck, J F Gerkens, G R Wilkinson and R A Branch
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 479-483;

  4. Gerold, M

    1. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
      M Gerold, R Eigenmann, F Hefti, A Daum and G Haeusler
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 624-633;

  5. Gibson, J K

    1. Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
      E Patterson, J K Gibson and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 453-458;

  6. Goldberg, D M

    1. Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons.
      S R Goldberg, W H Morse and D M Goldberg
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 500-509;

  7. Goldberg, S R

    1. Behavioral effects of nicotine: schedule-controlled responding by squirrel monkeys.
      R D Spealman, S R Goldberg and M L Gardner
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 484-491;
    2. Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons.
      S R Goldberg, W H Morse and D M Goldberg
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 500-509;

  8. Gómez, B

    1. Analysis of the cerebrovascular effects of 5-hydroxytryptamine in unanesthetized goats.
      G Dieguez, B Gómez and S Lluch
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 599-603;

  9. Green, T P

    1. Pharmacologic determinants of ototoxicity of furosemide in the chinchilla.
      T P Green, L P Rybak, B L Mirkin, S K Juhn and T Morizono
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 537-542;

  10. Gross, D M

    1. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
      D M Gross, C S Sweet, E H Ulm, E P Backlund, A A Morris, D Weitz, D L Bohn, H C Wenger, T C Vassil and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 552-557;
    2. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
      C S Sweet, D M Gross, P T Arbegast, S L Gaul, P M Britt, C T Ludden, D Weitz and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 558-566;

H

  1. Haeusler, G

    1. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
      M Gerold, R Eigenmann, F Hefti, A Daum and G Haeusler
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 624-633;

  2. Hefti, F

    1. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
      M Gerold, R Eigenmann, F Hefti, A Daum and G Haeusler
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 624-633;

  3. Henderson, G I

    1. Inhibition of placental valine uptake after acute and chronic maternal ethanol consumption.
      G I Henderson, D Turner, R V Patwardhan, L Lumeng, A M Hoyumpa and S Schenker
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 465-472;

  4. Herz, A

    1. Pharmacological characterization of the epsilon-opiate receptor.
      R Schulz, M Wüster and A Herz
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 604-606;

  5. Holmberg, S

    1. Differential biosynthesis of prostaglandins by hydronephrotic rabbit and cat kidneys.
      D F Reingold, K Watters, S Holmberg and P Needleman
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 510-515;

  6. Hoyumpa, A M

    1. Inhibition of placental valine uptake after acute and chronic maternal ethanol consumption.
      G I Henderson, D Turner, R V Patwardhan, L Lumeng, A M Hoyumpa and S Schenker
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 465-472;

I

  1. Ishii, K

    1. Postsynaptic alpha-2 adrenergic receptors in isolated rat islets of Langerhans: inhibition of insulin release and cyclic 3':5'-adenosine monophosphate accumulation.
      T Nakaki, T Nakadate, K Ishii and R Kato
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 607-612;

J

  1. Juhn, S K

    1. Pharmacologic determinants of ototoxicity of furosemide in the chinchilla.
      T P Green, L P Rybak, B L Mirkin, S K Juhn and T Morizono
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 537-542;

K

  1. Kamal, L A

    1. Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine.
      L A Kamal, S Arbilla and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 592-598;

  2. Kato, R

    1. Postsynaptic alpha-2 adrenergic receptors in isolated rat islets of Langerhans: inhibition of insulin release and cyclic 3':5'-adenosine monophosphate accumulation.
      T Nakaki, T Nakadate, K Ishii and R Kato
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 607-612;

  3. Kelleher, R T

    1. Self-administration of cocaine derivatives by squirrel monkeys.
      R D Spealman and R T Kelleher
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 532-536;

  4. Kilpatrick, B F

    1. Inhibition of two monomeric butyrylcholinesterases from rabbit liver by chlorpromazine and other drugs.
      R S Rush, A R Main, B F Kilpatrick and G D Faulkner
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 586-591;

  5. Kirkendol, P L

    1. Effect of reserpine pretreatment on in vivo femoral arterial responses to vasodilator agents.
      C A Cauvin, C J Devia and P L Kirkendol
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 447-452;

  6. Klaassen, C D

    1. Uptake of galactose, ouabain and taurocholate into centrilobular and periportal enriched hepatocyte subpopulations.
      N H Stacey and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 634-639;

  7. Koda, L Y

    1. Interaction of ethanol and nutrition during gestation: influence on maternal and offspring development in the rat.
      S G Wiener, W J Shoemaker, L Y Koda and F E Bloom
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 572-579;

L

  1. Lamb, R G

    1. Effect of morphine exposure on mouse liver triglyceride formation.
      R G Lamb and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 496-499;

  2. Langer, S Z

    1. Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine.
      L A Kamal, S Arbilla and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 592-598;

  3. Lazar, M A

    1. Tyrosine hydroxylase: studies on the phosphorylation of a purified preparation of the brain enzyme by the cyclic AMP-dependent protein kinase.
      A M Edelman, J D Raese, M A Lazar and J D Barchas
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 647-653;

  4. Lluch, S

    1. Analysis of the cerebrovascular effects of 5-hydroxytryptamine in unanesthetized goats.
      G Dieguez, B Gómez and S Lluch
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 599-603;

  5. Lucchesi, B R

    1. Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
      E Patterson, J K Gibson and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 453-458;

  6. Ludden, C T

    1. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
      C S Sweet, D M Gross, P T Arbegast, S L Gaul, P M Britt, C T Ludden, D Weitz and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 558-566;

  7. Lumeng, L

    1. Inhibition of placental valine uptake after acute and chronic maternal ethanol consumption.
      G I Henderson, D Turner, R V Patwardhan, L Lumeng, A M Hoyumpa and S Schenker
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 465-472;

M

  1. Main, A R

    1. Inhibition of two monomeric butyrylcholinesterases from rabbit liver by chlorpromazine and other drugs.
      R S Rush, A R Main, B F Kilpatrick and G D Faulkner
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 586-591;

  2. Makman, M H

    1. The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain.
      M R Rosenfeld and M H Makman
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 526-531;

  3. McGovren, J P

    1. Sex- and age-related mouse toxicity and disposition of the amino acid antitumor agent, acivicin.
      J P McGovren, G L Neil, P J Chan and J C Stewart
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 433-440;

  4. Mirkin, B L

    1. Pharmacologic determinants of ototoxicity of furosemide in the chinchilla.
      T P Green, L P Rybak, B L Mirkin, S K Juhn and T Morizono
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 537-542;

  5. Morizono, T

    1. Pharmacologic determinants of ototoxicity of furosemide in the chinchilla.
      T P Green, L P Rybak, B L Mirkin, S K Juhn and T Morizono
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 537-542;

  6. Morris, A A

    1. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
      D M Gross, C S Sweet, E H Ulm, E P Backlund, A A Morris, D Weitz, D L Bohn, H C Wenger, T C Vassil and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 552-557;

  7. Morse, W H

    1. Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons.
      S R Goldberg, W H Morse and D M Goldberg
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 500-509;

  8. Mullin, M J

    1. Ethanol and functional tolerance: interactions with pimozide and clonidine.
      M J Mullin and A P Ferko
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 459-464;

N

  1. Nakadate, T

    1. Postsynaptic alpha-2 adrenergic receptors in isolated rat islets of Langerhans: inhibition of insulin release and cyclic 3':5'-adenosine monophosphate accumulation.
      T Nakaki, T Nakadate, K Ishii and R Kato
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 607-612;

  2. Nakaki, T

    1. Postsynaptic alpha-2 adrenergic receptors in isolated rat islets of Langerhans: inhibition of insulin release and cyclic 3':5'-adenosine monophosphate accumulation.
      T Nakaki, T Nakadate, K Ishii and R Kato
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 607-612;

  3. Needleman, P

    1. Differential biosynthesis of prostaglandins by hydronephrotic rabbit and cat kidneys.
      D F Reingold, K Watters, S Holmberg and P Needleman
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 510-515;

  4. Neil, G L

    1. Sex- and age-related mouse toxicity and disposition of the amino acid antitumor agent, acivicin.
      J P McGovren, G L Neil, P J Chan and J C Stewart
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 433-440;

O

  1. O'Leary, T D

    1. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
      T D O'Leary and L N Sansom
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 613-616;

P

  1. Pang, P K

    1. Hypotensive action of synthetic fragments of parathyroid hormone.
      P K Pang, M C Yang, T E Tenner, J K Chang and M Shimizu
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 567-571;

  2. Patterson, E

    1. Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
      E Patterson, J K Gibson and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 453-458;

  3. Patwardhan, R V

    1. Inhibition of placental valine uptake after acute and chronic maternal ethanol consumption.
      G I Henderson, D Turner, R V Patwardhan, L Lumeng, A M Hoyumpa and S Schenker
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 465-472;

  4. Petitclerc, C

    1. Renal excretion of levamisole.
      G E Plante, R Erian and C Petitclerc
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 617-623;

  5. Plante, G E

    1. Renal excretion of levamisole.
      G E Plante, R Erian and C Petitclerc
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 617-623;

Q

  1. Quebbemann, A J

    1. The acute effects of furosemide, ethacrynic acid and chlorothiazide on the renal tubular handling of uric acid in the chicken.
      J R Shideman, M J Zmuda and A J Quebbemann
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 441-446;

R

  1. Raese, J D

    1. Tyrosine hydroxylase: studies on the phosphorylation of a purified preparation of the brain enzyme by the cyclic AMP-dependent protein kinase.
      A M Edelman, J D Raese, M A Lazar and J D Barchas
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 647-653;

  2. Reingold, D F

    1. Differential biosynthesis of prostaglandins by hydronephrotic rabbit and cat kidneys.
      D F Reingold, K Watters, S Holmberg and P Needleman
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 510-515;

  3. Reinke, L A

    1. Postnatal development of mixed-function oxidation and conjugation in hemoglobin-free perfused rat liver.
      B R Sonawane, S J Yaffe, L A Reinke and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 473-478;

  4. Roche, E B

    1. Effect of hypophysectomy and castration on hepatic, pulmonary and intestinal aryl hydrocarbon hydroxylase activities in the rat.
      W A Al-Turk, S J Stohs and E B Roche
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 492-495;

  5. Rosenfeld, M R

    1. The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain.
      M R Rosenfeld and M H Makman
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 526-531;

  6. Roth, L

    1. Renal excretion of cimetidine.
      I M Weiner and L Roth
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 516-520;

  7. Rush, R S

    1. Inhibition of two monomeric butyrylcholinesterases from rabbit liver by chlorpromazine and other drugs.
      R S Rush, A R Main, B F Kilpatrick and G D Faulkner
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 586-591;

  8. Rybak, L P

    1. Pharmacologic determinants of ototoxicity of furosemide in the chinchilla.
      T P Green, L P Rybak, B L Mirkin, S K Juhn and T Morizono
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 537-542;

S

  1. Sansom, L N

    1. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
      T D O'Leary and L N Sansom
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 613-616;

  2. Schenker, S

    1. Inhibition of placental valine uptake after acute and chronic maternal ethanol consumption.
      G I Henderson, D Turner, R V Patwardhan, L Lumeng, A M Hoyumpa and S Schenker
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 465-472;

  3. Schulz, R

    1. Pharmacological characterization of the epsilon-opiate receptor.
      R Schulz, M Wüster and A Herz
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 604-606;

  4. Shannon, H E

    1. Evaluation of phencyclidine analogs on the basis of their discriminative stimulus properties in the rat.
      H E Shannon
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 543-551;

  5. Shideman, J R

    1. The acute effects of furosemide, ethacrynic acid and chlorothiazide on the renal tubular handling of uric acid in the chicken.
      J R Shideman, M J Zmuda and A J Quebbemann
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 441-446;

  6. Shimizu, M

    1. Hypotensive action of synthetic fragments of parathyroid hormone.
      P K Pang, M C Yang, T E Tenner, J K Chang and M Shimizu
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 567-571;

  7. Shoemaker, W J

    1. Interaction of ethanol and nutrition during gestation: influence on maternal and offspring development in the rat.
      S G Wiener, W J Shoemaker, L Y Koda and F E Bloom
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 572-579;

  8. Sonawane, B R

    1. Postnatal development of mixed-function oxidation and conjugation in hemoglobin-free perfused rat liver.
      B R Sonawane, S J Yaffe, L A Reinke and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 473-478;

  9. Spealman, R D

    1. Behavioral effects of nicotine: schedule-controlled responding by squirrel monkeys.
      R D Spealman, S R Goldberg and M L Gardner
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 484-491;
    2. Self-administration of cocaine derivatives by squirrel monkeys.
      R D Spealman and R T Kelleher
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 532-536;

  10. Stacey, N H

    1. Uptake of galactose, ouabain and taurocholate into centrilobular and periportal enriched hepatocyte subpopulations.
      N H Stacey and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 634-639;

  11. Stewart, J C

    1. Sex- and age-related mouse toxicity and disposition of the amino acid antitumor agent, acivicin.
      J P McGovren, G L Neil, P J Chan and J C Stewart
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 433-440;

  12. Stewart, J J

    1. Interactions of reserpine and morphine on rat intestinal transit.
      J J Stewart
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 521-525;

  13. Stohs, S J

    1. Effect of hypophysectomy and castration on hepatic, pulmonary and intestinal aryl hydrocarbon hydroxylase activities in the rat.
      W A Al-Turk, S J Stohs and E B Roche
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 492-495;

  14. Stone, C A

    1. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
      D M Gross, C S Sweet, E H Ulm, E P Backlund, A A Morris, D Weitz, D L Bohn, H C Wenger, T C Vassil and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 552-557;
    2. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
      C S Sweet, D M Gross, P T Arbegast, S L Gaul, P M Britt, C T Ludden, D Weitz and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 558-566;

  15. Sweet, C S

    1. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
      D M Gross, C S Sweet, E H Ulm, E P Backlund, A A Morris, D Weitz, D L Bohn, H C Wenger, T C Vassil and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 552-557;
    2. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
      C S Sweet, D M Gross, P T Arbegast, S L Gaul, P M Britt, C T Ludden, D Weitz and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 558-566;

T

  1. Tenner, T E

    1. Hypotensive action of synthetic fragments of parathyroid hormone.
      P K Pang, M C Yang, T E Tenner, J K Chang and M Shimizu
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 567-571;

  2. Thurman, R G

    1. Postnatal development of mixed-function oxidation and conjugation in hemoglobin-free perfused rat liver.
      B R Sonawane, S J Yaffe, L A Reinke and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 473-478;

  3. Turner, D

    1. Inhibition of placental valine uptake after acute and chronic maternal ethanol consumption.
      G I Henderson, D Turner, R V Patwardhan, L Lumeng, A M Hoyumpa and S Schenker
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 465-472;

U

  1. Ulm, E H

    1. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
      D M Gross, C S Sweet, E H Ulm, E P Backlund, A A Morris, D Weitz, D L Bohn, H C Wenger, T C Vassil and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 552-557;

V

  1. Vassil, T C

    1. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
      D M Gross, C S Sweet, E H Ulm, E P Backlund, A A Morris, D Weitz, D L Bohn, H C Wenger, T C Vassil and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 552-557;

  2. Verbeeck, R K

    1. Disposition of furosemide in functionally hepatectomized dogs.
      R K Verbeeck, J F Gerkens, G R Wilkinson and R A Branch
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 479-483;

  3. Vollmer, R R

    1. Influence of dietary sodium on renin angiotensin system involvement in sodium nitroprusside hypotension in conscious rats.
      R R Vollmer, E N Bush and M M Abukhres
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 580-585;

W

  1. Watters, K

    1. Differential biosynthesis of prostaglandins by hydronephrotic rabbit and cat kidneys.
      D F Reingold, K Watters, S Holmberg and P Needleman
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 510-515;

  2. Weiner, I M

    1. Renal excretion of cimetidine.
      I M Weiner and L Roth
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 516-520;

  3. Weitz, D

    1. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
      D M Gross, C S Sweet, E H Ulm, E P Backlund, A A Morris, D Weitz, D L Bohn, H C Wenger, T C Vassil and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 552-557;
    2. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
      C S Sweet, D M Gross, P T Arbegast, S L Gaul, P M Britt, C T Ludden, D Weitz and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 558-566;

  4. Wenger, H C

    1. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
      D M Gross, C S Sweet, E H Ulm, E P Backlund, A A Morris, D Weitz, D L Bohn, H C Wenger, T C Vassil and C A Stone
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 552-557;

  5. Wiener, S G

    1. Interaction of ethanol and nutrition during gestation: influence on maternal and offspring development in the rat.
      S G Wiener, W J Shoemaker, L Y Koda and F E Bloom
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 572-579;

  6. Wilkinson, G R

    1. Disposition of furosemide in functionally hepatectomized dogs.
      R K Verbeeck, J F Gerkens, G R Wilkinson and R A Branch
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 479-483;

  7. Wüster, M

    1. Pharmacological characterization of the epsilon-opiate receptor.
      R Schulz, M Wüster and A Herz
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 604-606;

Y

  1. Yaffe, S J

    1. Postnatal development of mixed-function oxidation and conjugation in hemoglobin-free perfused rat liver.
      B R Sonawane, S J Yaffe, L A Reinke and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 473-478;

  2. Yang, M C

    1. Hypotensive action of synthetic fragments of parathyroid hormone.
      P K Pang, M C Yang, T E Tenner, J K Chang and M Shimizu
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 567-571;

Z

  1. Zmuda, M J

    1. The acute effects of furosemide, ethacrynic acid and chlorothiazide on the renal tubular handling of uric acid in the chicken.
      J R Shideman, M J Zmuda and A J Quebbemann
      Journal of Pharmacology and Experimental Therapeutics March 1981, 216 (3) 441-446;
Back to top

In this issue

Advertisement